Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
about
A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancerEvaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinomaMatrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.Molecular pathology of tumor metastasis. I. Predictive pathology.Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity.Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Mast cells--a role in periodontal diseases?The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma.Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsElevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomasAssessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.Active MMP-2 effectively identifies the presence of colorectal cancer.Metalloproteinases and their regulators in colorectal cancer.On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds.The gelatinases, their activators and inhibitors in the progression of colorectal cancer.Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.Effects of homeodomain protein CDX2 expression on the proliferation and migration of lovo colon cancer cells.Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells.Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells.Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis.The relation of gelatinase (MMP-2 and -9) expression with distant site metastasis and tumour aggressiveness in colorectal cancer.Proteolysis in human breast and colorectal cancer.Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumorsSimple and sensitive electrogenerated chemiluminescence peptide-based biosensor for detection of matrix metalloproteinase 2 released from living cells.The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis.
P2860
Q33261253-647ACD9C-2B8A-4108-9142-979D60F09466Q33262265-AD61FF73-A158-43F7-8C2C-EE7464274658Q33280468-1CCE9F13-EBEA-4D1B-891A-F2700150F443Q33403635-2F7AFC51-D9A7-483B-A5CF-5E0ACFDD141BQ33867768-B73398B2-9339-4523-A6E2-75ABCD799229Q34161592-824C189D-1E7C-491F-AED5-C044CD068178Q34427045-435D228F-F05F-4888-A57A-6B8F560A5968Q34711492-40EEAAB4-EB31-48B7-89FC-13FEE262E597Q34786508-9BD8FB92-05DA-44E2-BB5B-3F51A6B3882AQ35104008-D2FC9799-6EC2-4346-BEBD-5234ADB311E1Q35166309-4332F96F-F852-4FF0-943A-293BB9469667Q35169992-5B7C84B4-9501-4AAA-9C9A-B6E0A40A184CQ35772663-D30BCBC2-1C8E-4D04-87E5-43462D296949Q35778326-B61D4BA2-DFE4-4644-B702-09D0FF4A67C7Q35889918-80EDD80B-9F81-4686-B185-9A5AD067F779Q36014448-F50906B0-A052-4DF4-AC2E-EDE063840CF5Q36075298-16A1EF60-5C7A-4A0D-BFA9-8560B452B0DEQ36500327-039756DA-DAFD-423F-A4FA-6A0A2B028458Q36611209-A32BE0FB-32C0-4D51-B8EF-04C368AC5928Q36644626-3870B363-C7E2-4535-9C6B-6507D0271716Q36715291-DFD7426E-AA34-4C1C-ABC6-8956E9DC0D45Q36746744-1679A4C7-0F3B-41EE-8F9F-FC5FF7C9DB3EQ37400120-70E85FE1-4CE1-48EB-9E71-CEAE43702BF0Q37415978-BFAB86F0-BDF5-4FE3-BBC1-B76EBA389ED8Q37663884-6AA82B07-4CE2-490B-836B-DD137FD44A97Q37836419-B942E74D-46F3-4064-8286-6C7EF5E3E7C9Q38098234-F535AEF0-0213-413F-9004-7C95755DCCD5Q38274250-552464FB-C35C-4B7E-97C5-FDCCE786C912Q39310229-EE353CA5-7F96-44C8-907A-CB27A1E97404Q39533321-693451B1-3800-4645-997C-4B521E094B49Q40135772-6038C043-9987-4245-94D3-B3762C1EF32BQ40153723-0DBEDB46-77DC-42BA-858B-06B41F7722F6Q40398026-E6FD2A42-27A3-43A3-A217-DB9BD18E15A5Q40799982-237E6189-95D5-46F4-8F4B-A7564348FA4FQ40978388-239456EC-9CF4-4F7D-B087-08D567DCFC5EQ41904146-AD01D852-F1E0-46CB-A995-2F36817D82BCQ42095382-102988A9-C9C0-4DB8-A975-A95029DD6809Q42144367-C1833883-5621-4926-87B9-0AA20AE624B1Q46585795-D830066B-1B84-4F1B-9000-1B99E17B2673Q47137146-FF1750A5-812D-45A4-B3CA-A8977EFC6EAC
P2860
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
@en
Gelatinase
@nl
type
label
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
@en
Gelatinase
@nl
prefLabel
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
@en
Gelatinase
@nl
P2093
P2860
P356
P1476
Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
@en
P2093
N R Griffin
P A Clarke
S A Watson
S L Parsons
P2860
P2888
P304
P356
10.1038/BJC.1998.712
P407
P577
1998-12-01T00:00:00Z